Air pollution, metabolites and respiratory health across the life-course

Abstract

Previous studies have explored the relationships of air pollution and metabolic profiles with lung function. However, the metabolites linking air pollution and lung function and the associated mechanisms have not been reviewed from a life-course perspective. Here, we provide a narrative review summarising recent evidence on the associations of metabolic profiles with air pollution exposure and lung function in children and adults. Twenty-six studies identified through a systematic PubMed search were included with 10 studies analysing air pollution-related metabolic profiles and 16 studies analysing lung function-related metabolic profiles. A wide range of metabolites were associated with short- and long-term exposure, partly overlapping with those linked to lung function in the general population and with respiratory diseases such as asthma and COPD. The existing studies show that metabolomics offers the potential to identify biomarkers linked to both environmental exposures and respiratory outcomes, but many studies suffer from small sample sizes, cross-sectional designs, a preponderance on adult lung function, heterogeneity in exposure assessment, lack of confounding control and omics integration. The ongoing EXposome Powered tools for healthy living in urbAN Settings (EXPANSE) project aims to address some of these shortcomings by combining biospecimens from large European cohorts and harmonised air pollution exposure and exposome data.

Ambient air pollution exposure linked to long COVID among young adults: a nested survey in a population-based cohort in Sweden

“…Moreover, little is known about the importance of the timing of air pollution exposure, for example early-life exposure when the lungs are thought to be more susceptible to environmental exposure, or exposure later in life. 30 , 31 …”

Organoid technology and applications in lung diseases: Models, mechanism research and therapy opportunities

“…Owing to natural lung aging and the constant exposure of humans to air pollution, cigarettes, and viruses, lung diseases are the leading cause of morbidity and mortality worldwide ( Calvert and Ryan Firth, 2020 ; Lozano et al, 2012 ). Lung diseases range from common diseases such as lung cancer, influenza, and asthma to genetic disease cystic fibrosis (CF) and the novel coronavirus disease COVID-19 ( Gruzieva et al, 2022 ). Very few treatment options are available for patients with advanced and recurrent diseases.…”

Linking air pollution exposure to blood-based metabolic features in a community-based aging cohort

“…Air pollutants have been associated with mortality 1 and diseases 2 involving the pulmonary 3 , cardiovascular 4 , and nervous system 5 . These associations have been attributed to system-wide changes induced by air pollution exposure including oxidative stress 6 , inflammation 7 , and changes in circulating metabolites 8 . Long term exposure to fine particulate matter with aerodynamic diameter ≤ 2.5 µm (PM2.5), particulate matter with aerodynamic diameter ≤ 10 µm (PM10), and nitrogen dioxide (NO2) has been associated with decline in cognitive function 9,10 and exposure to PM2.5 has been associated with clinical aggravation of age-related neurodegenerative diseases 11 .…”